News • SCN tumor development
How prostate cancer grows aggressive to evade treatment
In a new study, UCLA researchers demonstrated how small cell neuroendocrine prostate cancer tumor cells can arise from less aggressive prostate tumors.
Prostate cancer
News • Nuclear medicine
Prostate cancer: staging issues in bone scans compared with PSMA PET
Bone scans have been found to overstage prostate cancer at initial staging compared to prostate specific membrane antigen (PSMA) PET, according to new research.
News • AI-based imaging and reporting solutions for MRI
Philips partners with imaging biomarker specialist Quibim
Philips and Quibim have signed a multi-year agreement to work on an integrated solution including an AI-based software to automate real-time prostate gland segmentation in MR images.
News • Surge in under 50s in past decades
The rising tide of early-onset cancers
Cancer has become strikingly more common in people under 50 in the past three decades, an international research team finds. The reseachers explore what this means for future death tolls.
News • Imaging for targeted biopsy
MRI and ultrasound "fusion" improves prostate cancer detection
Combining ultrasound and MRI technology can help detect prostate cancer at an earlier stage and potentially save lives, according to new University of Dundee research.
News • Prostate cancer detection
Personalized PSA screening may improve accuracy
The accuracy of prostate-specific antigen (PSA) screening can be improved by including genetic factors that cause changes in PSA levels not associated with cancer, according to a multi-center study.
News • Perilous PSA policy
Prostate cancer ‘test by request’ drives overdiagnosis, argue experts
Experts argue that shared decision policies between patients and their doctors have led to high rates of PSA testing and clear medical harm, with minimal benefit and inequity.
News • Oncology & Cancer
Research uncovers alternate mechanism for producing key protein in metastatic prostate cancer
Like the better-known prostate-specific antigen (PSA), prostate-specific membrane antigen (PSMA) is a biomarker that can tell physicians much about a patient's metastatic prostate cancer.
News • Radiotherapy trial
Prostate cancer: radical approach greatly reduces treatment visits
A new clinical trial has shown that men diagnosed with prostate cancer can benefit from ‘radical radiotherapy’ that delivers treatment in five hospital visits instead of the typical 20.
News • PSMA-PET/CT
Advanced imaging may help in clinical treatment of prostate cancer
An advanced imaging method is showing promise as a way to improve the diagnosis of prostate cancer by giving clinicians a clearer view of suspected tumours during biopsy.
News • Augmented reality system
AR-powered free-hand, real-time needle guidance for prostate cancer diagnosis
Researchers demonstrate a HoloLens AR system that enables accurate, flexible needle guidance for transperineal prostate interventions such as biopsy, focal laser ablation, and brachytherapy
News • Rapid screening diagnostic
94% accuracy: new prostate cancer blood test beats PSA method
Researchers have developed a new blood test to detect prostate cancer which displays greater accuracy than the current prostate-specific antigen (PSA) method.
News • Nuclear medicine
Prostate cancer: PSMA PET/MRI accurately predicts recurrence risk
In men recently diagnosed with intermediate or high-grade prostate cancer, PSMA PET/MRI can successfully determine whether their cancer is likely to return within two years of a prostatectomy.
News • Stereotactic body radiotherapy
Advanced radiotherapy speeds up prostate cancer treatment
An advanced radiotherapy technique can be used to safely treat prostate cancer patients in as little as one to two weeks, compared with the current standard, which takes one to two months.
News • Equivalent outcomes in 5 vs 8-week treatment
High-risk prostate cancer: Study confirms effectiveness of shortened radiation therapy
A new randomized study confirms that men with high-risk prostate cancer can be treated with a moderately shortened course (5 vs. 8 weeks) of radiation therapy.
News • Focal therapy study
New prostate cancer treatment to reduce risk of impotence
Focal treatment of prostate cancer involves treating only the tumor and not the entire gland, sparing surrounding tissue and nerves. The method is being evaluated in a research study.
Article • Interpreter of maladies
Will AI help realize the promise of precision medicine?
Machine learning and artificial intelligence (AI) have the potential to transform cancer treatment management worldwide. Their ability to rapidly analyse and integrate routinely acquired diverse data will improve the accuracy and effectiveness of precision medical treatments.
News • Determining aggressiveness
New discovery improves prostate cancer prognosis
Researchers in Sweden have now discovered a faster and easier way to determine who has an aggressive form of prostate cancer, and who has not.
News • Clinical trial
Prostate cancer: Researchers explore new radiotherapy approach
A different way of treating people with prostate cancer will be investigated by researchers at the University of Leeds in a new clinical trial funded by Yorkshire Cancer Research.
News • Cancer imaging
MRI 2.0 lights up cancerous tissue
Synthetic correlated diffusion makes cancerous tissue glow in medical images could help doctors more accurately detect and track the progression of cancer over time.
News • New imaging approach
Diagnosing prostate cancer with ultrasound
UK researchers have found that a new type of ultrasound scan can diagnose most prostate cancer cases with good accuracy in a clinical trial involving 370 men.
News • Calculating cancer
Virtual patient ‘surrogates’ to personalise cancer treatments
Mathematical models used as patient surrogates could help clinicians select the best cancer treatment before going to the patient’s bedside.
News • Easy-to-use
Free tool could reduce prostate cancer biopsies
A new risk calculator could reduce the number of unnecessary and invasive biopsies for prostate cancer.
News • Reduced harm, reduced costs
Prostate cancer: MRI and blood test improve screening
The combination of a novel blood test and magnetic resonance imaging can reduce overdiagnosis of low-risk cancers as well as societal costs in prostate cancer screening, according to a new study.
News • BRCA and prostate, pancreatic cancers
Faulty 'breast cancer gene' BRCA also dangerous for men
Faulty versions of the BRCA1 and BRCA2 genes are well known to increase the risk of breast and ovarian cancer. Now, they have been linked to several other cancers, including those that affect men.
